دورية أكاديمية

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial

التفاصيل البيبلوغرافية
العنوان: Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial
المؤلفون: Kristensen, Lars ErikAff1, IDs40744024006545_cor1, Keiserman, Mauro, Papp, KimAff3, Aff4, McCasland, Leslie, White, DouglasAff6, Aff7, Carter, Kyle, Lippe, Ralph, Photowala, Huzefa, Drogaris, Leonidas, Soliman, Ahmed M., Chen, Michael, Padilla, Byron, Behrens, Frank
المصدر: Rheumatology and Therapy. 11(3):617-632
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:21986576
21986584
DOI:10.1007/s40744-024-00654-5